Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/11951
Title: Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL).
Authors: Ellis, Kathryn A;Szoeke, Cassandra;Bush, Ashley I;Darby, David G;Graham, Petra L;Lautenschlager, Nicola T;Macaulay, S Lance;Martins, Ralph N;Maruff, Paul;Masters, Colin L;McBride, Simon J;Pike, Kerryn E;Rainey-Smith, Stephanie R;Rembach, Alan;Robertson, Joanne;Rowe, Christopher C;Savage, Greg;Villemagne, Victor L;Woodward, Michael M;Wilson, William;Zhang, Ping;Ames, David
Institutional Author: AIBL Research Group
Affiliation: National Ageing Research Institute (NARI), Parkville, Victoria, Australia.
CogState Limited, Melbourne, Victoria, Australia.
Latrobe University, Melbourne, Victoria, Australia.
Sir James McCusker Alzheimer's Disease Research Unit (Hollywood Private Hospital), Perth, WA, Australia.
Florey Institute of Neuroscience and Mental Health (MHRI), Parkville, Victoria, Australia.
Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia.
Macquarie University, Sydney, NSW, Australia.
Austin Health, Aged Care, Heidelberg, Victoria, Australia.
Commonwealth Scientific and Industrial Research Organisation, Preventative Health Flagship, CMSE CMIS (CSIRO), Parkville, Victoria, Australia.
Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne; St. Vincent's Aged Psychiatry Service, St George's Hospital, Kew, Victoria, Australia.
Issue Date: 20-Nov-2013
Citation: International Psychogeriatrics / Ipa 2013; 26(4): 543-54
Abstract: The Australian Imaging, Biomarkers and Lifestyle (AIBL) Flagship Study of Ageing is a prospective study of 1,112 individuals (211 with Alzheimer's disease (AD), 133 with mild cognitive impairment (MCI), and 768 healthy controls (HCs)). Here we report diagnostic and cognitive findings at the first (18-month) follow-up of the cohort. The first aim was to compute rates of transition from HC to MCI, and MCI to AD. The second aim was to characterize the cognitive profiles of individuals who transitioned to a more severe disease stage compared with those who did not.Eighteen months after baseline, participants underwent comprehensive cognitive testing and diagnostic review, provided an 80 ml blood sample, and completed health and lifestyle questionnaires. A subgroup also underwent amyloid PET and MRI neuroimaging.The diagnostic status of 89.9% of the cohorts was determined (972 were reassessed, 28 had died, and 112 did not return for reassessment). The 18-month cohort comprised 692 HCs, 82 MCI cases, 197 AD patients, and one Parkinson's disease dementia case. The transition rate from HC to MCI was 2.5%, and cognitive decline in HCs who transitioned to MCI was greatest in memory and naming domains compared to HCs who remained stable. The transition rate from MCI to AD was 30.5%.There was a high retention rate after 18 months. Rates of transition from healthy aging to MCI, and MCI to AD, were consistent with established estimates. Follow-up of this cohort over longer periods will elucidate robust predictors of future cognitive decline.
Internal ID Number: 24252258
URI: http://ahro.austin.org.au/austinjspui/handle/1/11951
DOI: 10.1017/S1041610213001956
URL: http://www.ncbi.nlm.nih.gov/pubmed/24252258
Type: Journal Article
Subjects: Aged
Aged, 80 and over
Aging.pathology.psychology
Alzheimer Disease.blood.diagnosis
Australia
Biological Markers.blood
Case-Control Studies
Cognition
Disease Progression
Female
Follow-Up Studies
Humans
Life Style
Magnetic Resonance Imaging
Male
Middle Aged
Mild Cognitive Impairment.blood.diagnosis
Neuroimaging
Neuropsychological Tests.statistics & numerical data
Positron-Emission Tomography
Prospective Studies
Socioeconomic Factors
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.